Login / Signup

Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.

Morten Hasselstrøm JensenClaus DethlefsenOle HejlesenPeter Vestergaard
Published in: Journal of diabetes science and technology (2019)
The delay in CGM is still an issue. The delay in this study was identified to be 9 minutes compared to PG. With a simple post-processing approach of time shifting the CGM measurements with -9 minutes, it was possible to obtain a statistically significantly lower MARD and subsequently obtain clinical research endpoints of improved validity.
Keyphrases
  • clinical trial
  • open label
  • phase iii
  • double blind